Bone loss at subchondral plate in knee osteoarthritis patients with hypertension and type 2 diabetes mellitus

Osteoarthritis and Cartilage

Volumn 21, Issue 11, 2013, Pages 1716-1723

  Wen, C Y ^a   Chen, Y ^a   Tang, H L ^b   Yan, C H ^a   Lu, W W ^a   Chiu, K Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hypertension; Microstructure; Osteoarthritis; Subchondral plate; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; BONE INJURY; CLINICAL ARTICLE; COMORBIDITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INFORMED CONSENT; KNEE OSTEOARTHRITIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOLYSIS; POROSITY; PRIORITY JOURNAL; SUBCHONDRAL BONE PLATE; COMPLICATION; HYPERTENSION; MICRO-COMPUTED TOMOGRAPHY; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TIBIA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OSTEOPOROSIS; POROSITY; TIBIA; X-RAY MICROTOMOGRAPHY;

EID: 84884986730     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.06.027     Document Type: Article

References (42)

1. Zhang Y., Jordan J.M. Epidemiology of osteoarthritis. Rheum Dis Clin North America 2008, 34:515-529.
2. Mahjoub M., Berenbaum F., Houard X. Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012, 23(Suppl 8):S841-S846.
3. Suri S., Walsh D.A. Osteochondral alterations in osteoarthritis. Bone 2012, 51:204-211.
4. Lories R.J., Luyten F.P. The bone-cartilage unit in osteoarthritis. Nature reviews. Rheumatology 2011, 7:43-49.
5. Prasadam I., van Gennip S., Friis T., Shi W., Crawford R., Xiao Y. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthritis Rheum 2010, 62:1349-1360.
6. Couchourel D., Aubry I., Delalandre A., Lavigne M., Martel-Pelletier J., Pelletier J.P., et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 2009, 60:1438-1450.
7. Sanchez C., Deberg M.A., Bellahcene A., Castronovo V., Msika P., Delcour J.P., et al. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 2008, 58:442-455.
8. Sanchez C., Deberg M.A., Piccardi N., Msika P., Reginster J.Y., Henrotin Y.E. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 2005, 13:988-997.
9. McErlain D.D., Ulici V., Darling M., Msika P., Reginster J.Y., Henrotin Y.E. An invivo investigation of the initiation and progression of subchondral cysts in a rodent model of secondary osteoarthritis. Arthritis Res Ther 2012, 14:R26.
10. Hilal G., Massicotte F., Martel-Pelletier J., Fernandes J.C., Pelletier J.P., Lajeunesse D. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. JBone Miner Res: Official J Am Soc Bone Miner Res 2001, 16:713-721.
11. Lajeunesse D. The role of bone in the treatment of osteoarthritis. Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 2004, 12(Suppl A):S34-S38.
12. Hochberg M.C., Lethbridge-Cejku M., Tobin J.D. Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging. Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 2004, 12(Suppl A):S45-S48.
13. Sridhar M.S., Jarrett C.D., Xerogeanes J.W., Labib S.A. Obesity and symptomatic osteoarthritis of the knee. JBone Joint Surg Br 2012, 94:433-440.
14. Kerkhof H.J., Lories R.J., Meulenbelt I., Jonsdottir I., Valdes A.M., Arp P., et al. Agenome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum 2010, 62:499-510.
15. Valdes A.M., Spector T.D., Tamm A., Kisand K., Doherty S.A., Dennison E.M., et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 2010, 62:2347-2352.
16. Singh G., Miller J.D., Lee F.H., Pettitt D., Russell M.W. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care 2002, 8:S383-S391.
17. Zhuo Q., Yang W., Chen J., Wang Y. Metabolic syndrome meets osteoarthritis. Nature reviews. Rheumatology 2012, 8:729-737.
18. Nuesch E., Dieppe P., Reichenbach S., Williams S., Iff S., Juni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011, 342:d1165.
19. Findlay D.M. Vascular pathology and osteoarthritis. Rheumatology (Oxford) 2007, 46:1763-1768.
20. Conaghan P.G., Vanharanta H., Dieppe P.A. Is progressive osteoarthritis an atheromatous vascular disease?. Ann Rheum Dis 2005, 64:1539-1541.
21. Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad Med J 2012, 88:240-242.
22. Yoshimura N., Muraki S., Oka H., Tanaka S., Kawaguchi H., Nakamura K., et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 2012, 20:1217-1226.
23. Metz J.A., Morris C.D., Roberts L.A., McClung M.R., McCarron D.A. Blood pressure and calcium intake are related to bone density in adult males. Br JNutr 1999, 81:383-388.
24. Lethbridge-Cejku M., Tobin J.D., Scott W.W., Cauley J.A. Axial and hip bone mineral density and radiographic changes of osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. JRheumatol 1996, 23:1943-1947.
25. Vestergaard P., Rejnmark L., Mosekilde L. Hypertension is a risk factor for fractures. Calcified Tissue Int 2009, 84:103-111.
26. Schwartz A.V., Vittinghoff E., Bauer D.C., Hillier T.A., Strotmeyer E.S., Ensrud K.E., et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 2011, 305:2184-2192.
27. Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. JBone Mineral Res 2007, 22:1317-1328.
28. Liow R.Y., Walker K., Wajid M.A., Bedi G., Lennox C.M. The reliability of the American knee society score. Acta Orthopaedica Scand 2000, 71:603-608.
29. Saleh A.S., Najjar S.S., Muller D.C., Shetty V., Ferrucci L., Gelber A.C., et al. Arterial stiffness and hand osteoarthritis: a novel relationship? Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 2007, 15:357-361.
30. van den Berg W.B. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 2011, 19:338-341.
31. Burr D.B., Radin E.L. Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis?. Rheum Dis Clin North America 2003, 29:675-685.
32. Leaverton P.E., Peregoy J., Fahlman L., Sangeorzan E., Barrett J.P. Does diabetes hide osteoarthritis pain?. Med Hypotheses 2012, 78:471-474.
33. Schett G., Kleyer A., Perricone C., Sahinbegovic E., Iagnocco A., Zwerina J., et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care 2013, 36:403-409.
34. Waine H., Nevinny D., Rosenthal J., Joffe I.B. Association of osteoarthritis and diabetes mellitus. Tufts Folia Med 1961, 7:13-19.
35. Sturmer T., Brenner H., Brenner R.E., Gunther K.P. Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study. Scand J Rheumatol 2001, 30:169-171.
36. Caterson B., Baker J.R., Christner J.E., Pollok B.A., Rostand K.S. Diabetes and osteoarthritis. Ala J Med Sci 1980, 17:292-299.
37. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
38. Nielen M.M., van Sijl A.M., Peters M.J., Verheij R.A., Schellevis F.G., Nurmohamed M.T. Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet Disord 2012, 13:150.
39. Sowers J.R., White W.B., Pitt B., Whelton A., Simon L.S., Winer N., et al. The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med 2005, 165:161-168.
40. Ilic K., Obradovic N., Vujasinovic-Stupar N. The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review. Calcif Tissue Int 2013, 92:217-227.
41. Botter S.M., van Osch G.J., Clockaerts S., Waarsing J.H., Weinans H., van Leeuwen J.P. Osteoarthritis induction leads to early and temporal subchondral plate porosity in the tibial plateau of mice: an invivo microfocal computed tomography study. Arthritis Rheum 2011, 63:2690-2699.
42. Wen C.Y., Wu C.B., Tang B., Wang T., Yan C.H., Lu W.W., et al. Collagen fibril stiffening in osteoarthritic cartilage of human beings revealed by atomic force microscopy. Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc 2012, 20:916-922.